hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang下一页:癫痫患者手术评估新型工具
- 2022-05-02科研 | STTT: 生酮饮食改变菌群降低结肠3HG淋巴细胞,缓解小鼠结肠炎
- 2022-05-02上海医疗机构同月成功为小年龄儿童完成Wada试验
- 2022-04-28青年人癫痫病因有哪些
- 2022-04-26隐源性病症死亡率翻倍
- 2022-04-13上海率先探索异地就医门诊费直接结算
- 2022-04-12癫痫治疗障碍仍难以克服
- 癫痫治疗障碍仍难以克服
- 综述:癫痫持续状态诊治最新进展
- 预测癫痫患者再入院风险
- GW制药Epidiolex治疗Dret综合征获得欧盟孤儿药资格
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- FDA批准Aptiom用于治疗患者癫痫发作
- 抗癫痫药物预防新发癫痫:任重而道远
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 治疗癫痫 治疗癫痫偏方大全
- 2016AAN:神经专家发表了有前途的专业见解
- 月经性癫痫患者妊娠期癫痫控制更好
- 癫痫猝死:凶手是谁?
- 三庚酸酯可治疗1型转运体缺陷综合征
- 癫痫发作的症状及急救措施
- 癫痫发作的症状是什么?
- 脑梗死的症状是什么有这些前兆要谨慎
- 不注意这些问题,吃多少药都没用!
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 【用药情报站】临床应用应听取各种药种药物禁忌证?
- 癫痫患者手术评估新型工具
- 2013国际抗癫痫联合会抗癫痫药用指南
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 北京癫痫手术费用
- NeuroImage:纤维球成像可用于癫痫的进展
- 成人羊角风病的病因是什么?
- 癫痫的诊断应该了解哪些症状?
- 河南:无偿献血者用血费用一站式减免
- 北京癫痫癫痫病医院化疗费用
- 小儿癫痫病有什么征状
- 治疗癫痫适当用药四大原则
- 20120816cctv10健康之路:周文静说明了脑部结构
- 癫痫病症状 怎样眼科癫痫病人
- 致使癫痫病的病因有哪些?
- 研究称肉类绦虫患者的癫痫由p物质引起
- 癫痫病治疗最低款项
- 怎么了解癫痫病的副作用与治疗
- 癫痫病吃什蜂蜜好处多
- 癫痫病能彻底痊愈吗 癫痫病怎么办
- NeuroImage:纤维球成像可用于癫痫病因进展
- 儿童癫痫病的早期症状 临床分类及展示出